Heart Test Laboratories enters $2.51M note purchase agreement with Streeterville Capital, net proceeds $1.86M

HeartSciences Inc.

Issued $2.51M unsecured promissory note to Streeterville Capital; 8.5% interest, 18-month maturity, $500K OID.
Net proceeds of $1.86M after OID and $10K transaction expenses; used for general working capital.
Monthly redemption cap of $270K starting March 2025; balance increases 5% if not reduced by $900K by Sept 2025.
Placement agents Maxim Group and Ascendiant Capital received 7% commission on gross proceeds.
Note sold in unregistered transaction relying on Section 4(2) exemption; HSCS listed on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.